KL, klotho, 9365

N. diseases: 332; N. variants: 20
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0338656
Disease: Impaired cognition
Impaired cognition
0.100 AlteredExpression disease BEFREE These results suggest that the upregulation of Klotho expression in the brain may promote the autophagic clearance of amyloid beta and protect against cognitive deficits in AD mice. 30851437 2019
CUI: C0338656
Disease: Impaired cognition
Impaired cognition
0.100 GeneticVariation disease BEFREE In conclusion, Klotho G-395 A polymorphisms were associated with urolithiasis and cardiovascular disease but not with cognitive impairment. 30633899 2019
CUI: C0338656
Disease: Impaired cognition
Impaired cognition
0.100 Biomarker disease BEFREE Furthermore, the results do not support the hypothesis that KL-VS has a modifying effect on Aβ burden and APOE ε4-driven cognitive decline in preclinical AD. 30716541 2019
CUI: C0338656
Disease: Impaired cognition
Impaired cognition
0.100 AlteredExpression disease BEFREE The serum klotho level is a potential predictor of cerebrovascular disease in hemodialysis patients, but it is not an independent risk factor of cognitive impairment for hemodialysis patients with cerebrovascular disease. 30791885 2019
CUI: C0338656
Disease: Impaired cognition
Impaired cognition
0.100 Biomarker disease BEFREE Most notably, Klotho deficiency is associated with a phenotype comprising organ manifestations accompanying aging including atherosclerosis and cognitive impairment. 31055648 2019
CUI: C0338656
Disease: Impaired cognition
Impaired cognition
0.100 Biomarker disease BEFREE Most notably, Klotho deficiency is associated with a phenotype comprising organ manifestations accompanying aging including atherosclerosis and cognitive impairment. 29274997 2018
CUI: C0338656
Disease: Impaired cognition
Impaired cognition
0.100 AlteredExpression disease BEFREE A reduced blood α-Klotho level was correlated with grading of cerebral DWMLs and was accompanied by cognitive decline as an independent risk factor. 29154273 2018
CUI: C0338656
Disease: Impaired cognition
Impaired cognition
0.100 Biomarker disease BEFREE The present study is to investigate the effects of LIG on cognitive deficits and metabolism of both APP and Klotho and its underlying mechanism in AD double-transgenic (APP/PS1) mice and cultured human cells. 29163135 2017
CUI: C0338656
Disease: Impaired cognition
Impaired cognition
0.100 Biomarker disease BEFREE Although the absence of the age-regulating klotho protein causes klotho-deficient mice to rapidly develop cognitive impairment and increasing klotho enhances hippocampal-dependent memory, the cellular effects of klotho that mediate hippocampal-dependent memory function are unknown. 28837861 2017
CUI: C0338656
Disease: Impaired cognition
Impaired cognition
0.100 Biomarker disease BEFREE Latency of klotho-/- mice in passive avoidance test was larger in linagliptin group than in control group (P < 0.05), indicating the amelioration of cognitive impairment by linagliptin. 29195509 2017
CUI: C0338656
Disease: Impaired cognition
Impaired cognition
0.100 AlteredExpression disease BEFREE Our current study indicates that klotho upregulation may be a neuroprotective mechanism of simvastatin against cognitive decline in AD. 27687042 2017
CUI: C0338656
Disease: Impaired cognition
Impaired cognition
0.100 GeneticVariation disease BEFREE The haplotype effect was stronger than that of KL-VS. Two variants, rs2283368 and rs9526984, were the only variants significantly associated with cognitive decline over 7 years. 26405063 2016
CUI: C0338656
Disease: Impaired cognition
Impaired cognition
0.100 Biomarker disease BEFREE This observation substantiates data from other laboratories that have reported that loss of Klotho accelerates the development of aging-like phenotypes, including cognitive deficits, whereas Klotho overexpression extends life span and enhances cognition in mice and humans. 27125744 2016
CUI: C0338656
Disease: Impaired cognition
Impaired cognition
0.100 GeneticVariation disease BEFREE KLOTHO G-395A polymorphism associates with reduced cognitive impairment in a sample of Chinese nonagenarians and centenarians. 26732817 2016
CUI: C0338656
Disease: Impaired cognition
Impaired cognition
0.100 Biomarker disease BEFREE Augmenting klotho or its effects may enhance cognition and counteract cognitive deficits at different life stages. 24813892 2014